Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
A US federal judge has agreed to keep a dicamba drift lawsuit brought by a Missouri peach farmer against Bayer legacy company Monsanto and BASF separate from an array of class actions filed by soybean farmers whose crops were allegedly harmed by the herbicide.
Some 99.1 % of domestic food samples tested by the US Food and Drug Administration (FDA) in fiscal 2016 (ended September 30th) complied with pesticide tolerances, according to a report issued this month.
The Canadian Pest Management Regulatory Authority (PMRA) has proposed the cancellation of all uses of the ethylene bisdithiocarbamate (EBDC) fungicide, mancozeb, except for use on greenhouse tobacco, due to human health and environmental risk concerns.
Japanese company Mitsui & Co’s biopesticide subsidiary, Certis USA (Columbia, Maryland), has launched the Beauveria bassiana strain GHA-based bioinsecticide, BoteGHA, in the US.
The US EPA has approved US company OmniLytics’ (Sandy, Utah) bactericides, AgriPhage-Citrus Canker (Xanthomonas citri subsp citri bacteriophage) and AgriPhage Fire Blight (Erwinia amylovora bacteriophage).
US agrochemical and specialty chemical company, Albaugh (Ankeny, Iowa), has raised product prices following US President Trump administration’s imposition last month of an extra 10% tariff on imports of a long list of products from China.
The Canadian Pest Management Regulatory Agency (PMRA) has confirmed its decision to allow the continue registration of the bird repellent, methyl anthranilate, following a re-evaluation of the active ingredient.
BASF has received US approval for three products based on BASF/Meiji Seika Pharma’s new insecticide, afidopyropen (trade-marked as Inscalis), for use on a range of crops including fruit, vegetables and ornamentals.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.